UNASSIGNED: Endometrial fluid on the 5th day was significantly higher in the control group (28.0%) than in the interventional group (6.0%) (P < 0.001). Regarding pregnancy rate, although being higher in the interventional group (54.3% vs 50.0%), the difference was not statistically significant (P = 0.5). It was found that the intervention was associated with risk reduction of endometrial fluid (OR = 0.168, 95% CI = 0.065-0.429, P < 0.001.
UNASSIGNED: Aspiration of endometrial cavity fluid with diosmin intake increased the likelihood of fresh embryo transfer and with a slightly better pregnancy rate compared to conservative management.Clinical trial number: NCT02158000, Date of registration: 6/6/2014, Date of initial enrollment (first patient recruiting): 1/11/2014, URL: https://clinicaltrials.gov/ct2/show/NCT02158000.
■第5天,对照组子宫内膜液(28.0%)明显高于介入组(6.0%)(P<0.001)。关于怀孕率,虽然介入组较高(54.3%vs50.0%),差异无统计学意义(P=0.5)。结果发现干预与子宫内膜液风险降低相关(OR=0.168,95%CI=0.065~0.429,P<0.001。
■吸入含地奥司明的子宫内膜腔液增加了新鲜胚胎移植的可能性,与保守治疗相比,妊娠率略高。临床试验编号:NCT02158000,注册日期:2014年6月6日,初始招募日期(首次招募患者):2014年1月11日,URL:https://clinicaltrials.gov/ct2/show/NCT02158000。